Financial Results : Balsm Alofoq’s H1 2025 profit declines 6% to SAR 1.3M

Balsm Alofoq’s H1 2025 profit declines 6% to SAR 1.3M

11/08/2025 Argaam Exclusive

View other reports

Balsm Alofoq Medical Co. posted net profits of SAR 1.3 million in the first half of 2025, down 6% from SAR 1.4 million in H1 2024.



Current Half Annual Comparison (M)

Compared With The
Item H1 2024 H1 2025 Change‬
Revenues 9.55 9.76 2.2 %
Net Income 1.43 1.34 (6.4 %)
Average Shares 1.00 1.25 25.0 %
Earnings Per Share before unusual items (Riyal) 1.43 1.07 (25.1 %)
EPS (Riyal) 1.43 1.07 (25.1 %)

The six-month profit was weighed by new investments as the company expanded its business in the fields of medical services and the sale of medical devices and equipment.

 

During the same period, the company also expanded into the maintenance of medical equipment in the government sector.

 

On the other hand, revenues grew by 2.2% year-on-year (YoY) during the first six months of this year. This was mainly due to the company’s growth and expansion strategy and increased market share.

 

On a half-on-half basis, Balsm Alofoq’s six-month bottom line shrank by 59.8% from SAR 3.35 million in H2 2024.

 

Total shareholders’ equity, no minority interest, rose to SAR 30.26 million as of June 30, 2025, from SAR 15.82 million a year earlier.

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.